Literature DB >> 6065755

Hydrolysis of human leucocyte phospholipids by snake venoms.

C Klibansky, J Shiloah, A de Vries.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6065755     DOI: 10.1007/bf02144497

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS.

Authors:  Y RABINOWITZ
Journal:  Blood       Date:  1964-06       Impact factor: 22.113

2.  ACTION OF NAJA NAJA AND VIPERA PALESTINAE VENOMS ON CAT BRAIN PHOSPHOLIPIDS IN VITRO.

Authors:  C KLIBANSKY; J SHILOAH; A DEVRIES
Journal:  Biochem Pharmacol       Date:  1964-08       Impact factor: 5.858

3.  HEMOLYSIS AND SPLITTING OF HUMAN ERYTHROCYTE PHOSPHOLIPIDS BY SNAKE VENOMS.

Authors:  E CONDREA; A DEVRIES; J MAGER
Journal:  Biochim Biophys Acta       Date:  1964-02-24

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Mitochondrial swelling and phospholipid splitting induced by snake venoms.

Authors:  E Condrea; Y Avi-Dor; J Mager
Journal:  Biochim Biophys Acta       Date:  1965-11-22
  5 in total
  3 in total

1.  Removal of lipid from intact erythrocytes and ghosts by aqueous solutions and its relevance to membrane structure.

Authors:  J D Turner; G Rouser
Journal:  Lipids       Date:  1974-01       Impact factor: 1.880

2.  Biochemical properties of Egyptian Cerastes venoms in relation to geographic distribution.

Authors:  F Hassan; M F El-Hawary; A Gazawi; A Anis; S Wanas
Journal:  Z Ernahrungswiss       Date:  1980-12

3.  Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.

Authors:  B Damerau; L Lege; H D Oldigs; W Vogt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.